February 8th 2024
Phase 3 study reveals exebacase combined with standard antibiotics in treating methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and endocarditis did not meet its primary endpoints.
May 20th 2021
Rates of in-hospital mortality and days with bacteremia were similar between the two study cohorts.
June 11th 2020
The antibacterial is efficacious in a majority of patients in a small study.
February 19th 2020
The MRSA infection investigation was halted by the data and safety monitoring board due to concerns over acute kidney injury.
February 14th 2020
Therapy options have increased in recent decades, yet there is a lack of guidance.
Transferring Social Media Best Practices From Oncology to Antimicrobial Stewardship
Studies Dispel the Myth That Twitter Is a Waste of Time for Busy Clinicians
Hook Your Twitter Reader With Creative and Poetic Headlines
The Relationship Between Clinicians and Twitter
Twitter Is a Powerful Medium for Antimicrobial Stewardship Programs
Potential Antimicrobial Stewardship Interventions
Inappropriate Prescription of Antibiotics and Other Causes of Antimicrobial Resistance
Social Media Adds Value to Antimicrobial Stewardship Programs
Antibiotic-Resistant Infections Could Kill Millions Globally by 2050, OECD Says: Public Health Watch
New report highlights risks and costs associated with these infections equal to roughly 1 million deaths and $65 billion in the United States.
Iclaprim Non-Inferior to Vancomycin in Treating Patients with Wound Infections
Data from a pooled analysis of the REVIVE-1 and 2 studies found iclaprim to be non-inferior to vancomycin based on earl clinical response in patients with wound infections.
US Health Care-Associated Infection Progress Report Shows Some Improvement
A new report from the CDC shows substantial progress on the incidence of health care-associated infections in the United States, but there is still more work to be done.
Top 5 Key Takeaways from ID Week 2018
ID Week 2018 was held October 2-7, 2018, in San Francisco, California. The conference featured results of new studies on a variety of infectious disease topics as well as advancements being made in the field. Here are 5 key takeaways from the meeting.
Adding Fosfomycin to Daptomycin Could Improve Outcomes of MRSA Bacteremia
The combination of daptomycin plus fosfomycin was more effective than daptomycin alone for treating patients with MRSA bacteremia.
Top Infectious Disease News of the Week—September 2, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Telavancin Promising Potential Treatment Option for MRSA in Cystic Fibrosis Patients
Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis.
Use of Oritavancin as Outpatient Treatment for ABSSTIs Generates Potential Cost Savings at Community Hospital
Additional evidence supports the use of oritavancin as a cost-saving outpatient treatment for acute bacterial skin and skin structure infections (ABSSTIs) in patients who would otherwise be admitted to the hospital for therapy.
Top Infectious Disease News of the Week—August 19, 2018
Examining Social and Emotional Outcomes for Patients with Hospital-Acquired Infections
A new review examines previous studies and concludes that healthcare professionals could benefit from sensitivity training when dealing with patients who have HAIs.
A “Substantial Proportion” of Hospital MRSA Infections Occur Post-Discharge, Study Concludes: Public Health Watch
The results are significant given the ongoing debate regarding the role of contact precautions for the gram-positive bacteria.
Management of Gram-Positive Multidrug-Resistant Infections: The Role of Long-Acting Lipoglycopeptides
Gram-positive multidrug-resistant infections may be managed effectively with a single dose of long-acting lipo­glycopeptide antibiotics in the outpatient setting; however, careful patient selection is important for maximizing the cost-benefit of these relatively expensive drugs.
Alleged Penicillin Allergies Lead to Higher Risk of MRSA and C difficile
Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.
Penicillin Allergy Testing in Antibiotic Stewardship
Study suggests that clinicians should perform confirmatory allergy testing on patients with reported penicillin allergies as an important feature of antimicrobial stewardship.
Oritavancin Useful for Managing Serious Infections in Cancer Patients
Oritavancin is a useful antimicrobial option to help clinicians manage MRSA infections and other serious GPC infections in patients with cancer, including in those at the end-of-life.
Skin and Soft Tissue Infections on the Decline, Yet Still High Among Patients with HIV
Skin and soft tissue infections appear to be on the decline in the general population, but individuals with HIV have a higher risk.
FDA Files Complaint Against Company Selling Unapproved Antiseptics Claiming to Prevent Infections
The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.
Future of OPAT for ABSSSI
Establishing a Protocol for OPAT
Long-Acting Lipoglycopeptide Antibiotics for ABSSSI
Risk Stratification for ABSSSI
Cost Considerations for the Treatment of ABSSSI
2 Commerce Drive Cranbury, NJ 08512